PDS Biotechnology (PDSB) Operating Leases (2019 - 2023)
PDS Biotechnology's (PDSB) quarterly Operating Leases came in at $59650.0 in Q2 2023, little changed YoY from $59650.0 in Q2 2022, and little changed on a QoQ basis from $59650.0 in Q2 2022.
PDS Biotechnology (PDSB) Operating Leases (2019 - 2023) Analysis & Trends
PDS Biotechnology (PDSB) has 5 years of Operating Leases data on file, last reported at $59650.0 in Q2 2023.
- Quarterly Operating Leases changed 0.0% year-over-year to $59650.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $59650.0 (changed 0.0% YoY) and the FY2021 annual result came in at $231430.0, down 52.8% from the prior year.
- Operating Leases steadied at $59650.0 in Q2 2023, from $59650.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $902972.0 in Q1 2019 to a low of $59650.0 in Q2 2022.
- A 5-year average of $408909.3 and a median of $426802.5 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases tumbled 84.91% — and 2023, when it changed 0.0%.
- Tracing PDSB's Operating Leases over 5 years: stood at $774278.0 in 2019, then slumped by 36.67% to $490353.0 in 2020, then sank by 52.8% to $231430.0 in 2021, then tumbled by 74.23% to $59650.0 in 2022, then changed by 0.0% to $59650.0 in 2023.
- The last three Operating Leases figures came in at $59650.0 (Q2 2023), $59650.0 (Q2 2022), and $146980.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | PDS Biotechnology | 11.58 Mn | 11.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 59,650.00 |
| Jun 30, 2022 | 59,650.00 |
| Mar 31, 2022 | 146,980.00 |
| Dec 31, 2021 | 231,430.00 |
| Sep 30, 2021 | 313,976.00 |
| Jun 30, 2021 | 395,314.00 |
| Mar 31, 2021 | 458,291.00 |
| Dec 31, 2020 | 490,353.00 |
| Sep 30, 2020 | 521,692.00 |
| Jun 30, 2020 | 552,326.00 |
| Jun 30, 2019 | 774,278.00 |
| Mar 31, 2019 | 902,972.00 |